NIFTY 50▲24,213.30
217.95 (0.91%)
SENSEX▲79,476.63
694.39 (0.88%)
NIFTY BANK▲52,207.25
992.00 (1.94%)
TATA MOTORS▲835.65
11.55 (1.40%)
SUZLON ENERGY▲67.37
1.05 (1.58%)
TATA STEEL▲152.29
5.34 (3.63%)
INDIAN RAILWAY FINANCE CORP▼151.44
-1.80 (-1.17%)
TATA POWER▲434.10
5.05 (1.18%)
RAIL VIKAS NIGAM▲450.90
4.70 (1.05%)
RELIANCE INDUSTRIES▲1,305.30
3.15 (0.24%)
VODAFONE IDEA▲8.14
0.26 (3.30%)
ZOMATO▼241.87
-3.21 (-1.31%)
RELIANCE POWER▼41.52
-0.51 (-1.21%)
INDIAN RENEWABLE ENERGY▼204.77
-0.61 (-0.30%)
ADANI POWER▲603.45
18.45 (3.15%)
YES BANK▲20.62
0.29 (1.43%)
STATE BANK OF INDIA▲849.20
19.35 (2.33%)
NHPC▼80.18
-3.12 (-3.75%)
HDFC BANK▲1,757.85
43.75 (2.55%)
OLA ELECTRIC MOBILITY LTD▼74.18
-6.66 (-8.24%)
JIO FIN SERVICES LTD▲321.90
2.05 (0.64%)
INDIAN OIL CORP▲140.80
1.87 (1.35%)
BHARAT ELECTRONICS▲286.35
2.20 (0.77%)
GTL INFRA▲2.20
0.09 (4.27%)
MRF▼1,19,530.15
-1346.60 (-1.11%)
ADANI PORT & SEZ▼1,329.35
-19.90 (-1.47%)
JAIPRAKASH POWER VENTURES▲17.96
0.08 (0.45%)
ITC▼480.20
-4.40 (-0.91%)
Bal Pharma Share Price
BALPHARMA
₹127.00+₹2.55 (2.05%) TodayLast updated on 05 Nov, 2024 | 15:26 IST
Bal Pharma Share Price Chart
Please wait...
About Bal Pharma
Bal Pharma Financials
Market cap ₹198 Crs | Open ₹124.00 | Close ₹124.45 |
Circuit range ₹130.67 - ₹118.22 | Day range ₹120.20 - ₹128.40 | Year range ₹88.95 - ₹157.98 |
Volume 12,692 | Avg. traded ₹125.16 | Revenue (12m) ₹343 Crs |
Bal PharmaBal Pharma Limited is a pharmaceutical company, which is engaged in manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers range of APIs includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers range of formulations products covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.
Bal Pharma Key indicators
52 week high ₹157.98 | 52 week low ₹88.95 | P/E ratio 25.9 |
P/B ratio 2.71 | ROE 10.3% | ROCE 11.95% |
Dividend yield 0.94% | Debt/Equity ratio 1.28 | EPS 6.5 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Bal Pharma Fundamentals
Bal Pharma Financial Ratios
Operating profit margin10.63% | Net profit margin3.03% |
ROE10.3% | ROA2.9% |
ROCE11.95% |
Learn more
Bal Pharma Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹128.00 | ₹124.45 | -0.77% |
Fri, Nov 1 2024 | ₹128.00 | ₹125.41 | |
Thu, Oct 31 2024 | ₹124.00 | ₹123.98 | |
Wed, Oct 30 2024 | ₹116.00 | ₹121.21 | |
Tue, Oct 29 2024 | ₹117.00 | ₹117.23 | -1.51% |
Mon, Oct 28 2024 | ₹115.00 | ₹119.03 | |
Fri, Oct 25 2024 | ₹118.00 | ₹114.21 | -3.82% |
Thu, Oct 24 2024 | ₹119.00 | ₹118.75 | -0.53% |
Events
Corporate actions
Dividend • ₹1.2/share
Ex date 17 Sep 2024
Dividend • ₹1/share
Ex date 18 Sep 2023
Dividend • ₹1/share
Ex date 13 Sep 2022
Learn more
More